Yale Cancer Podcast Explores Drug Development Process
Dr Edward Chu from the Yale Cancer Center recently interviewed Dr Louis Denis of Pfizer Oncology. During the 30-minute program, the two physicians discussed how cancer drugs are developed, tested and approved for the pharmaceutical product pipeline.
The broadcast includes segments on Dr Denis’ previous work at the Cancer Therapy and Research Center in San Antonio, his current research and development position at Pfizer (NYSE: PFE), the company’s seven billion dollar commitment to cancer research, and U.S. Food and Drug Administration efforts to improve the drug approval process.
If you are a cancer patient interested in participating in trials of an investigational drug, you can find out which trials are recruiting by visiting www.clinicaltrials.gov.
Source: Yale Cancer Center Answers
Related Links: YALE Bulletin & Calendar; Friends of Cancer Research; Seattle Cancer Care Alliance; PBS
Related Video:
Tags: AROMASIN®; exemestane; medical oncology; prescription drug safety; clinical research; experimental cancer treatments; New London, Connecticut; Institute for Drug Development; MD Anderson Cancer Center
Print This
|
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URI
Leave a comment
Browse All Categories: Next article: Human Skin Cells That Act Like Embryonic Stem Cells
Previous article: Radiation Reduces Risk of Second Laryngeal Cancer

